Yüklüyor......
Establishment of a neuroendocrine prostate cancer model driven by the RNA splicing factor SRRM4
Neuroendocrine prostate cancer (NEPC) is becoming more prevalent as more potent androgen receptor (AR) pathway inhibitors are applied to patients with metastatic tumors. However, there are limited cell and xenograft models currently available, hindering the investigation of signal pathways involved...
Kaydedildi:
| Yayımlandı: | Oncotarget |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Impact Journals LLC
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5620142/ https://ncbi.nlm.nih.gov/pubmed/28978002 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19916 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|